Nuveen, LLC Geron Corp Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Geron Corp stock. As of the latest transaction made, Nuveen, LLC holds 2,850,769 shares of GERN stock, worth $4.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,850,769Holding current value
$4.05 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GERN
# of Institutions
303Shares Held
451MCall Options Held
1.07MPut Options Held
648K-
Black Rock Inc. New York, NY46.6MShares$66.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.1MShares$48.5 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA30MShares$42.6 Million1.72% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$38.7 Million11.75% of portfolio
-
State Street Corp Boston, MA27.2MShares$38.6 Million0.0% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $537M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...